...
首页> 外文期刊>Indian journal of pharmaceutical sciences. >HPTLC Marker-based Analysis of Madhuram, a Pre-diabetic Proprietary Poly Herbal
【24h】

HPTLC Marker-based Analysis of Madhuram, a Pre-diabetic Proprietary Poly Herbal

机译:基于HPTLC MADHURAM的基于糖尿病专有的Poly Herbal分析

获取原文
获取原文并翻译 | 示例
           

摘要

Proper validation of traditional medical knowledge using current scientific techniques and reasoning is vital before complementary and alternative medicinal products are integrated into conventional clinical practice. The present study was designed to standardize a proprietary Ayurvedic polyherbal preparation, Madhuram. Concocted as a mixture of six popular antidiabetic herbs as per Ayurvedic therapeutics, this is being prescribed as a health supplement in prediabetes. Capsule contents were processed for HPTLC analysis based on markers phyllanthin, berberine, ellagic acid, gallic acid, gymnemic acid and sennoside B through sample enrichment and were quantified against reference standards. The retention factors were phyllanthin 0.35 +/- 0.03, berberine 0.32 +/- 0.02, gallic acid 0.41 +/- 0.02, ellagic acid 0.29 +/- 0.04, gymnemic acid 0.36 +/- 0.01 and sennoside B 0.41 +/- 0.01 in their respective solvent systems. The peaks for phyllanthin, berberine, gallic acid, ellagic acid, gymnemic acid in their respective chromatograms of the formulation authenticated the raw material. Sennoside B was not detected in its enriched fraction of sample. Quantitation by densiometric scanning followed by peak integration demonstrated the presence of 3.17 mu g of phyllanthin, 4.92 mu g of berberine, 72 mu g of gallic acid, 66 mu g of ellagic acid, 410 mu g of gymnemic acid. The evaluation of antidiabetic poly herbal established the identity of label claim herbs. Quantification of markers characteristic of each herb has laid the groundwork for batch to batch standardization to check its content uniformity.
机译:使用当前的科学技术与互补和替代药品集成在常规临床实践中,对传统医学知识的适当验证至关重要。本研究旨在标准化专有的阿育吠陀聚氯乙烯制剂,Madhuram。根据阿育吠陀治疗剂作为六种普遍的抗糖尿病草药混合物,这是在预先抛售的健康补充剂中进行的。通过样品富集,基于标记物,小檗碱,鞣花酸,无碱酸,幼虫酸和脑苷B处理HPTLC分析的胶囊内容物。保留因子是phyllanthin 0.35 +/- 0.03,小檗碱0.32 +/- 0.02,无碱酸0.41 +/- 0.02,鞣酸​​0.29 +/- 0.04,型液体酸0.36 +/- 0.01和尖峰B 0.41 +/- 0.01它们各自的溶剂系统。 Phyllanthin,小檗碱,小酸,鞣花酸,静形酸在其各自的配方色谱图中的峰验证了原料。在其富集的样品分数中未检测到胞苷B.通过密度扫描的定量,然后达到峰积分证明存在3.17μg的植物黄嘌呤,4.92μg小檗碱,72μg食小酸,66μg鞣花酸,410μg胎酸。抗糖尿病聚丙酯评价确定了标签索赔草药的身份。每个草药的标记特征的量化已经为批量标准化奠定了基础,以检查其内容均匀性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号